Multi-Resistant UTI Funding
From 1 November 2024, fosfomycin (UroFos), will be funded in the community for urinary tract infections.
POAC funding under this HealthPathway is no longer required.
From 1 November 2024, fosfomycin (UroFos), will be funded in the community for urinary tract infections.
POAC funding under this HealthPathway is no longer required.